LPL Financial’s Travere Therapeutics TVTX Stock Holding History
Bought
Maintained
Sold
Other funds holding TVTX
LPL Financial's TVTX Position: Q3 2026 in Review
LPL Financial reduced its Travere Therapeutics (TVTX) stake by 74% in Q3 2026, selling an estimated $1.29M and leaving 7,478 shares worth $440K. The position accounts for ﹤0.01% of the portfolio, ranked #5207.
LPL Financial first reported a position in TVTX in Q4 2025 and has held it in 4 quarters since. The position peaked at $1.63M in Q2 2026. 345 funds tracked by Wall St. Rank hold TVTX as of Q3 2026.
- LPL Financial held 7,478 shares of Travere Therapeutics worth $440K as of Q3 2026.
- LPL Financial sold 21,175 Travere Therapeutics shares in Q3 2026, an estimated $1.29M.
- Travere Therapeutics made up ﹤0.01% of LPL Financial's portfolio in Q3 2026, its #5207 holding.
- LPL Financial first reported a position in Travere Therapeutics in Q4 2025 and has held it in 4 quarters since.
- LPL Financial's Travere Therapeutics position peaked at $1.63M in Q2 2026.
- 345 funds tracked by Wall St. Rank held Travere Therapeutics as of Q3 2026.
Based on LPL Financial's 13F filing for Q3 2026, filed 6 Nov 2026.